Related Experiment Video
Updated: Jul 20, 2025

12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.5K
Bacterial outer-membrane vesicles promote Vγ9Vδ2 T cell oncolytic activity
Jack Firth1, Jingjing Sun2, Vaques George1
1Department of Biochemical Engineering University College London, London, United Kingdom.
Frontiers in Immunology
|August 2, 2023
Summary
Bacterial outer-membrane vesicles (OMVs) activate Vγ9Vδ2 T cells, which then exhibit potent anti-tumor activity against cancer cells. This finding highlights a promising new avenue for cancer immunotherapy development.
Area of Science:
- Immunology
- Microbiology
- Cancer Research
Background:
- Bacterial outer-membrane vesicles (OMVs) show potential for initiating anti-tumor immunity.
- The precise mechanisms of OMV-induced anti-tumor responses are not fully understood.
- Innate-like lymphocytes, such as γδ T cells, are hypothesized to play a role.
Purpose of the Study:
- To investigate the immune activation elicited by bacterial OMVs.
- To determine the role of γδ T cells in OMV-mediated anti-tumor immunity.
- To assess the cytotoxic potential of OMV-expanded γδ T cells against cancer cell lines.
Main Methods:
- Peripheral blood mononuclear cells (PBMCs) were co-cultured with specific E. coli OMVs.
- Immune activation was assessed via cell marker expression and cytokine analysis.
- Cytotoxicity assays were performed using OMV-activated γδ T cells and cancer cell lines.
Main Results:
- OMVs induced a significant inflammatory response with γδ T cell proliferation as the predominant outcome.
- Vγ9Vδ2 T cells were the main subset expanding post-OMV challenge.
- OMV-expanded Vγ9Vδ2 T cells demonstrated robust cytotoxicity against breast and leukemia cell lines.
Conclusions:
- OMV challenge stimulates the expansion of Vγ9Vδ2 T cells.
- These expanded Vγ9Vδ2 T cells possess significant anti-tumor capabilities.
- OMV-mediated immune activation of Vγ9Vδ2 T cells offers a potential therapeutic strategy for cancer.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
972
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
972
Immune Response Against Viral Pathogens
826
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
826
Tumor Immunotherapy
558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558
Lytic Cycle of Bacteriophages
70.9K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.9K
Vesicular Tubular Clusters
2.5K
After budding out from the ER membrane, some COPII vesicles lose their coat and fuse with one another to form larger vesicles and interconnected tubules called vesicular tubular clusters or VTCs. These clusters constitute a compartment at the ER-Golgi interface known as ERGIC (Endoplasmic Reticulum Golgi Intermediate Compartment). The ERGIC is a mobile membrane-bound cargo transport system that sorts proteins secreted from ER and delivers them to the Golgi.
With the help of motor proteins such...
With the help of motor proteins such...
2.5K
COP Coated Vesicles
7.9K
Membrane-enclosed structures called vesicles transport proteins and lipids across the cell. The vesicles derive their cargo from the plasma membrane, Golgi, ER, or endosome. Coated vesicles are spherical, protein-coated carriers with a 50–100 nm diameter that mediate bidirectional transport between the ER and the Golgi. The distribution of proteins between the ER and Golgi complex is dynamic and is maintained by different coated vesicles. Their formation is driven by the assembly of...
7.9K

